FDA Permits Marketing of the First Hand-held Device to Aid in the Detection of Bleeding in the Skull
Read more here


Galleon Pharmaceuticals Names Lynne Brookes Senior Vice President and Chief Business Officer
Read more here


Niiki Pharma Reports on Synergistic Activity of Novel Anti-Cancer Agent NKP-1339 with Other Anti-Cancer Agents
Read more here


BioAdvance Names Sam Katz as Chair and Elects J. Larry Jameson, M.D., Ph.D., and Lauren Lenfest as Directors
Read more here


QR Pharma Reports Results from SBIR Grant by NIA/NIH to Study Posiphen® and Metabolites in Various Models
Read more here


FDA Accepts Filing of New Drug Application (NDA) for Yaupon’s Proprietary Gel Formulation of Mechlorethamine Hydrochloride
Read more here


Niiki Pharma Announces Positive Interim Data from Ongoing Clinical Trial of Novel Anti-Cancer Agent NKP-1339
Read more here